Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
03/2003
03/12/2003EP1017689B1 Method for purifying phthalides
03/12/2003EP0923575B1 Cyclic ether compounds as sodium channel modulators
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003CN1402707A Trifluoromethyl-substd. spirocyclic ketoenols
03/12/2003CN1401642A Process for production of trimellitic anhydride by continuous oxidizing process
03/12/2003CN1401641A Dihydrofuran heterocyclic compounds and synthesis process thereof
03/12/2003CN1401631A Bis (amino carbonylnaphthol) derivs.
03/11/2003US6531704 Nanotechnology for engineering the performance of substances
03/11/2003US6531616 Contacting lactone compound with an oxalate in presence of a base and a solvent to form an intermediate mixture; reacting with a formaldehyde derivative to form a product mixture; isolating alpha - substituted hydrocarbylidene lactones
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531503 Benzofurane derivatives
03/11/2003US6531424 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical
03/11/2003CA2242351C Novel tricyclic compounds and drug compositions containing the same
03/11/2003CA2038416C Ascorbic acid derivatives
03/06/2003WO2003018571A1 M-aminophenol derivatives and colouring agents containing them
03/06/2003WO2003018569A1 Process for ascorbic acids using alkaline earth silicate catalysts
03/06/2003WO2003018568A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
03/06/2003WO2003018552A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003018070A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
03/06/2003WO2003018069A1 Preparation and diabetic use of gibberellins
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2003018003A1 Ascorbic acid derivatives with essential amino acids, nonessential amino acids that do not occur in protein
03/06/2003WO2003018001A1 Apolipo protein e secretion promoters
03/06/2003WO2003018000A1 Novel ascorbic acid compounds, methods of synthesis and application
03/06/2003WO2003017942A2 Ascorbic acid derivatives with amino acids
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002057224A3 Synthesis and antimicrobial activityof novel dicationic 'reversed amidines'
03/06/2003WO2002051779A3 Method for producing alcohols by hydrogenating carbonyl compounds
03/06/2003WO2002024672A3 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045726 Novel immunotherapeutic agents
03/06/2003US20030045581 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/06/2003US20030045572 Anti-inflammation analgesic preparation
03/06/2003US20030045571 Process and intermediates to prepare latanoprost
03/06/2003US20030045569 Difluoromethylene aromatic ethers as inhibitors of glycine transport
03/06/2003US20030045560 6-(Aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
03/06/2003US20030045518 Certain bis(thio-hydrazide amide) compounds significantly enhance the anticancer activity of taxol.
03/06/2003US20030045432 Phenyl-substituted cyclic ketoenols
03/06/2003CA2458681A1 M-aminophenol derivatives and colouring agents containing them
03/06/2003CA2458616A1 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/06/2003CA2458344A1 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
03/05/2003EP1288211A1 Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide
03/05/2003EP1288210A2 A method for producing optically active lactone compounds by using salen cobalt complexes having a CIS-Beta structure
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288186A2 Vinyl ether compounds and preparation process thereof
03/05/2003EP1286981A1 Method for the production of 2- coumarone and substituted 2-coumarones
03/05/2003EP1286980A2 Enantioselective process for preparing arylated lactones and derivatives
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286955A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003EP1286949A2 Process for the preparation of aniline compounds
03/05/2003EP1286944A2 A solvent exchange process
03/05/2003EP1286763A2 Counterflow reactor with a bundle of contact tubes
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP1185534B1 Benzopyrans annelated in c7-c8 with an aromatic heterocycle and compositions and (co)polymer matrices containing them
03/05/2003EP1082317B1 Method for producing phthalic anhydride by means of catalytic vapor-phase oxidation of o-xylol/naphthalene mixtures
03/05/2003EP1054859A4 Processes and intermediates useful to make antifolates
03/05/2003EP1030830B1 Process for preparing gamma-butyrolactone, butane-1,4-diol and tetrahydrofuran
03/05/2003EP1019368B1 Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1102587C Optically active beta-halo-gamma-crotonic lactone and its synthesis process
03/05/2003CN1102586C Gamma-butenolide containing aryl substituent at beta position and its solidphase synthesis process
03/05/2003CN1102585C Process for preparing ranitidine bismuth citrate
03/05/2003CN1102584C Catalyst and process for preparing tetrahydrofurfuryl alcohol
03/04/2003US6528668 Perfumes
03/04/2003US6528651 Ring cleavage deamination of a triazacylclohexane derivative with hydrogen chloride
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528510 HIV protease inhibitors
02/2003
02/27/2003WO2003016297A1 Lactone derivative, and plant growth regulator and rooting agent each containing the same as active ingredient
02/27/2003WO2003016275A1 Antiviral agent
02/27/2003WO2003016267A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
02/27/2003WO2003016265A1 Cyclic compound and ppar agonist
02/27/2003WO2003015774A1 Compounds effecting glucokinase
02/27/2003WO2003015769A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
02/27/2003WO2003015765A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
02/27/2003WO2003015761A1 Selective estrogen receptor modulators
02/27/2003WO2002096884A3 Substituted benzoylketones as herbicidal agents for use as plant treatment agent
02/27/2003WO2002085301A3 Indole, azaindole and related heterocyclic amidopiperazine derivatives
02/27/2003US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide
02/27/2003US20030040545 (R)-Chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
02/27/2003US20030040538 Novel substituted tricyclic compounds
02/27/2003CA2457644A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
02/27/2003CA2457037A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
02/27/2003CA2456150A1 Selective estrogen receptor modulators
02/26/2003EP1286409A1 Nonaqueous electrolytic solution and secondary battery containing the same
02/26/2003EP1285911A2 Arylsulfonanilide ureas
02/26/2003EP1284959A1 Compounds for modulating the rage receptor
02/26/2003EP0941221B1 Substituted dihydrobenzofurans as pde inhibitors
02/26/2003EP0885187B1 Diphenylethers, process and intermediate products for their preparation, and their use
02/26/2003CN1399626A Ethers of o-desmethyl venlafaxine
02/26/2003CN1398860A Tetrahydrofuran refining process
02/26/2003CN1398670A Catalyst for liquid phase hydrogenation of furaldehyde to prepare furfuralcohol and its use
02/26/2003CN1398667A Catalyst for preparing gamma-butyrolactone and silvan and its use
02/26/2003CN1102146C Synthesis of amidosulfourea containing substituted furan nucleus
02/26/2003CN1102142C Novel N-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 472